RXRαadL−/− mice are resistant to obesity and are
impaired in preadipocyte differentiation. (A)
RXRαadL−/− mice are resistant to HFD- and MSG-induced
obesity. Total body weight of CT and RXRαadL−/− (KO)
mice under RD (a and b), under HFD
(a) and after MSG treatment (b) was
measured weekly. The number of animals monitored in each group was
10–15 males. Values are expressed as the mean ± SEM.
(B) Reduced adipose tissue weight in
RXRαadL−/− mice under HFD or after MSG treatment
compared with CT mice. Inguinal (ING), interscapular (INT), and
retroperitoneal (RET) WAT weight was determined in 6-month-old CT and
RXRαadL−/− (KO) mice, fed with RD or HFD and after MSG
treatment. Each group was composed of 5–7 males. Values are expressed
as the mean ± SEM. (C) Impaired adipogenesis in
RXRαadL−/− mice. Cryosections of s.c. inguinal WAT from
6-month-old CT (a, c, and
e) and RXRαadL−/− (b,
d, and f) mice, under RD
(a and b), HFD (c and
d), and after MSG treatment (e and
f) were stained with hematoxylin and eosin.
(Scale bar, 160 μm.) The areas of at least 400 cells per sample were
determined with the NSURFX software (J. L.
Vonesch, Institut de Génétique et de Biologie
Moléculaire et Cellulaire Illkirch). The distribution of the cell
size is shown in the corresponding graphs to the right. Arrows point to
small adipocytes and preadipocytes or poorly differentiated adipocytes
in e and f, respectively.